• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors.

作者信息

Sawutz D G, Bode D C, Briggs G M, Reid J R, Canniff P, Caldwell L, Faltynek C R, Miller D, Dunn J A, de Garavilla L, Guiles J W, Weigelt C, Michne W, Treasurywala A M, Silver P J

机构信息

Department of Biochemistry, Sterling Winthrop Pharmaceuticals Research Division, Collegeville, PA 19426, USA.

出版信息

Biochem Pharmacol. 1996 Jun 28;51(12):1631-8. doi: 10.1016/0006-2952(96)00112-8.

DOI:10.1016/0006-2952(96)00112-8
PMID:8687478
Abstract

In this report, we describe the discovery and characterization of a novel biarylhydrazone series of platelet-derived growth factor (PDGF) receptor tyrosine kinase inhibitors typified by the prototype WIN 41662 (3-phenyl-N1-[1-(4-pytidyl)pyrimidine]hydrazone). WIN 41662 inhibited PDGF-stimulated autophosphorylation of PDGF receptors from human vascular smooth muscle cells (hVSMC) with an IC50 value of 60 nM. The inhibitor appeared to be competitive with respect to substrate (Mn(2+)-ATP), having a calculated Ki of 15 +/- 5 nM. WIN 41662 was approximately 500-fold more potent in inhibiting the PDGF receptor tyrosine kinase than the p56lck tyrosine kinase. It was inactive against other serine/threonine and tyrosine kinases tested. WIN 41662 produced concentration-dependent inhibition of PDGF-stimulated receptor autophosphorylation in intact hVSMC with an IC50 < 100 nM. Intracellular Ca2+ mobilization and cell proliferation were events that occurred in hVSMC subsequent to PDGF receptor activation. WIN 41662 inhibited PDGF-stimulated Ca2+ mobilization and cell proliferation ([3H]TdR incorporation) with IC50 values of 430 nM and 2.3 microM, respectively. These effects appeared to be specifically related to PDGF receptor tyrosine kinase inhibition since WIN 41662 was not cytotoxic (in vitro) and since WIN 72039, a close structural analog that does not inhibit PDGF receptor tyrosine kinase, also did not inhibit PDGF-stimulated receptor autophosphorylation, Ca2+ mobilization, or hVSMC proliferation. Thus, WIN 41662 is representative of a novel class of selective PDGF receptor tyrosine kinase inhibitors that inhibit PDGF-regulated secondary events in intact cells.

摘要

相似文献

1
In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors.
Biochem Pharmacol. 1996 Jun 28;51(12):1631-8. doi: 10.1016/0006-2952(96)00112-8.
2
Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.新型合成蛋白酪氨酸激酶抑制剂PD 089828对血管平滑肌中生长因子介导的酪氨酸磷酸化的抑制作用
J Pharmacol Exp Ther. 1997 Jun;281(3):1446-56.
3
In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.新型纳摩尔级强效且具有广泛活性的蛋白酪氨酸激酶抑制剂PD 166285的体外药理学特性
J Pharmacol Exp Ther. 1997 Dec;283(3):1433-44.
4
Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.细胞生长的抑制:酪氨酸激酶抑制剂CGP 53716的作用
J Pharmacol Exp Ther. 1997 Oct;283(1):402-10.
5
Indolocarbazoles: potent and selective inhibitors of platelet-derived growth factor receptor autophosphorylation.吲哚咔唑:血小板衍生生长因子受体自磷酸化的强效和选择性抑制剂。
Biochem Pharmacol. 1998 Feb 1;55(3):261-71. doi: 10.1016/s0006-2952(97)00460-7.
6
Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative.一种喹啉衍生物对血小板衍生生长因子(PDGF)受体自身磷酸化及PDGF介导的细胞事件的选择性抑制作用
Exp Cell Res. 1997 Aug 1;234(2):285-92. doi: 10.1006/excr.1997.3616.
7
Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.2-苯胺基嘧啶类蛋白酪氨酸激酶抑制剂对血小板衍生生长因子信号转导途径的选择性抑制作用
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2558-62. doi: 10.1073/pnas.92.7.2558.
8
Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib).BMS-354825(达沙替尼)对血管平滑肌细胞中血小板衍生生长因子诱导反应的强效抑制作用。
Mol Pharmacol. 2006 May;69(5):1527-33. doi: 10.1124/mol.105.020172. Epub 2006 Jan 25.
9
Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat.凝血因子Xa刺激大鼠培养血管平滑肌细胞中血小板衍生生长因子的释放和有丝分裂。
J Clin Invest. 1996 Sep 15;98(6):1493-501. doi: 10.1172/JCI118938.
10
In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.FGF-1受体酪氨酸激酶的选择性抑制剂PD 166866的体外生物学特性及抗血管生成作用
J Pharmacol Exp Ther. 1998 Jul;286(1):569-77.

引用本文的文献

1
Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy.选定的受体酪氨酸激酶抑制剂PD166285和PD173074的抗血管生成活性:对与光动力疗法联合治疗的意义。
Invest New Drugs. 1999;17(2):121-35. doi: 10.1023/a:1006367032156.
2
Signal transduction pathways and their relevance in human astrocytomas.信号转导通路及其在人类星形细胞瘤中的相关性。
J Neurooncol. 1997 Dec;35(3):223-48. doi: 10.1023/a:1005800114912.